Atlas Trials

Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery

Clinical trial NCT01859182 · WITHDRAWN

Trial details

NCT number
NCT01859182
Sponsor
National Cancer Institute (NCI)
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the GallbladderAdult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile DuctLocalized Unresectable Adult Primary Liver CancerMetastatic Extrahepatic Bile Duct CancerRecurrent Adult Primary Liver CancerRecurrent Extrahepatic Bile Duct CancerStage II Gallbladder CancerStage IIIA Gallbladder CancerStage IIIB Gallbladder Cancer
Start date
2013-01-01
Primary completion
2013-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.